{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:53:32Z","timestamp":1790744012055,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.lungcan.2018.12.030","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T11:24:55Z","timestamp":1546255495000},"page":"110-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-2549","authenticated-orcid":false,"given":"Yi-Tsz","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-3279","authenticated-orcid":false,"given":"Chia-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2018.12.030_bib0005","first-page":"203","article-title":"Severe cutaneous adverse reactions to drugs (SCAR): de\ufb01nitions, diagnostic criteria, genetic predisposition","volume":"27","author":"Roujeau","year":"2009","journal-title":"Dermatol. Sin."},{"issue":"1","key":"10.1016\/j.lungcan.2018.12.030_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2018.12.030_bib0015","first-page":"49","article-title":"Patch testing for adverse drug reactions","volume":"99","author":"Sekhon","year":"2017","journal-title":"Cutis"},{"issue":"9","key":"10.1016\/j.lungcan.2018.12.030_bib0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.lungcan.2018.12.030_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2018.12.030_bib0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1634\/theoncologist.2017-0582","article-title":"Osimertinib: a novel dermatologic adverse event profile in patients with lung cancer","volume":"23","author":"Chu","year":"2018","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.lungcan.2018.12.030_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5732\/cjc.014.10151","article-title":"Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer","volume":"34","author":"Huang","year":"2015","journal-title":"Chin. J. Cancer"},{"issue":"16","key":"10.1016\/j.lungcan.2018.12.030_bib0040","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1200\/JCO.2007.15.7883","article-title":"Fatal toxic epidermal necrolysis associated with cetuximab in a patient with colon cancer","volume":"26","author":"Lin","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.12.030_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2016.02.015","article-title":"Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient","volume":"95","author":"Doesch","year":"2016","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2018.12.030_bib0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2018.12.030_bib0055","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2147\/DDDT.S168248","article-title":"A case report of toxic epidermal necrolysis associated with AZD-9291","volume":"12","author":"Wang","year":"2018","journal-title":"Drug Des. Devel. Ther."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021830730X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021830730X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T18:42:54Z","timestamp":1550688174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950021830730X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":11,"alternative-id":["S016950021830730X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.12.030","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}